AMAL financial statements and SEC filings
AMAL annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $328.72M | – | $104.45M | 10-K |
| 2024-12-31 | $315.64M | – | $106.43M | 10-K |
| 2023-12-31 | $290.65M | – | $87.98M | 10-K |
| 2022-12-31 | $263.74M | – | $81.45M | 10-K |
| 2021-12-31 | $202.69M | – | $52.91M | 10-K |
| 2020-12-31 | $220.62M | – | $46.17M | 10-K |
AMAL annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $8.87B | $8.08B | $794.46M | 10-Q |
| 2024-12-31 | $8.26B | $7.55B | $707.65M | 10-K |
| 2023-12-31 | $7.97B | $7.39B | $585.36M | 10-K |
| 2022-12-31 | $7.84B | $7.33B | $508.95M | 10-K |
| 2021-12-31 | $7.08B | $6.51B | $563.88M | 10-K |
| 2020-12-31 | $5.98B | $5.44B | $535.82M | 10-K |
AMAL annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $135.78M | -$1.38M | $472.70M | 10-K |
| 2024-12-31 | $124.06M | -$1.77M | $162.06M | 10-K |
| 2023-12-31 | $117.22M | -$1.48M | $44.21M | 10-K |
| 2022-12-31 | $147.32M | -$1.67M | $788.22M | 10-K |
| 2021-12-31 | $70.54M | -$2.40M | $1.09B | 10-K |
| 2020-12-31 | $65.77M | -$1.61M | $605.60M | 10-K |